This is in agreement with the observations that the crosstalk between ERα and activated growth factor receptors, or their downstream kinases, in endocrine-resistant breast cancer cells supports the estrogen-independent activation of ERα (9). This evidence concerns the gene ESR1 and breast carcinoma.